A small biotechnology company specializing in oncology medicines approached promedim for help with medical monitoring of a planned Phase 3 oncology program. The company asked for promedim’s support to address a major internal audit finding.
By integrating promedim’s technology and medical team services with the client’s medical support, the Phase 3 oncology study completed successfully with demonstrable 24/7 coverage throughout the study duration.
Download the full case study here
